# 05-reproducibility-polish-p2-results

## 1. Objective

Apply P2 reproducibility/robustness polish after P0/P1 completion across both notebooks, focusing on:
- notebook-visible reproducibility evidence,
- tolerance checks where applicable,
- explicit internal-vs-external validation boundaries,
- clear future-work roadmap for external validation.

## 2. Reproducibility improvements

### A) `miRNA_qpcr_reanalysis.ipynb`

1. **Added notebook-visible fresh-kernel artifact checklist (new code cell after Cell 44)**
   - Generates and displays `repro_check_df` for expected outputs.
   - Saves `outputs/p2_reproducibility_artifact_check.csv`.
   - Purpose: make rerun completeness auditable from within the notebook.

2. **Updated reproducibility statement (Cell 46)**
   - Added explicit P2 language on:
     - fresh-kernel reproducibility evidence,
     - internal-only performance scope,
     - external-validation requirement,
     - optional future-work roadmap topics.

### B) `output/jupyter-notebook/2026-03-28-session-statistical-review-reproduction.ipynb`

1. **Added tolerance summary block (new code cell after Cell 32)**
   - Computes tolerance comparisons where reference artifacts are available.
   - Includes fallback row if no suitable reference is available.
   - Saves `outputs/session-statistical-review/p2_tolerance_summary.csv`.

2. **Updated closeout reproducibility narrative (Cell 34)**
   - Added explicit mention of tolerance summary and artifact consistency checks.
   - Clarified that local rerun completion does not override cross-review dependency ceilings.

3. **Updated bottom line + future-work roadmap (Cell 35)**
   - Added explicit internal-vs-external boundary statement.
   - Added clearly labeled external-validation roadmap section.

## 3. Remaining intrinsic limitations

1. **Internal validation only**: current conclusions are reproducible internally but remain within-dataset.
2. **No external cohort replication yet**: generalization and clinical-actionability remain unestablished.
3. **Proxy-variable dependency**: broader/global structure proxies remain a known interpretive limitation.
4. **Associational framework**: no causal identification design was introduced in P2.

## 4. Deferred Issues (if any)

| Issue_ID | Blocking level | Why deferred | What evidence/action unblocks it | Owner agent | Target prompt step |
|---|---|---|---|---|---|
| P2-DI-001 | moderate | External validation is outside current dataset and notebook scope. | Independent cohort replication with frozen preprocessing and pre-specified acceptance criteria. | miRNA Reanalysis Coordinator | 06 |
| P2-DI-002 | low | Tolerance summary is contingent on available historical reference artifacts; full cross-run CI benchmarking not always possible in a single run context. | Maintain versioned reference snapshots and run standardized rerun benchmarking protocol. | miRNA Reanalysis Coordinator | 06 |

## 5. Acceptance check

- ✅ Notebook narrative now separates reproducible-now (internal) vs external-validation-needed claims.
- ✅ No ambiguity remains about internal-only performance conclusions.
- ✅ Reproducibility evidence is notebook-visible (artifact checklist + tolerance summary).
- ✅ No hidden preprocessing was introduced.
